iSTAR Medical Revenue and Competitors

Wavre,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • iSTAR Medical's estimated annual revenue is currently $16.6M per year.(i)
  • iSTAR Medical's estimated revenue per employee is $251,000

Employee Data

  • iSTAR Medical has 66 Employees.(i)
  • iSTAR Medical grew their employee count by 5% last year.

iSTAR Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Senior Director Medical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is iSTAR Medical?

iSTAR Medical SA, headquartered in Wavre, Belgium, is a clinical stage medical technology company focused on the development of novel ophthalmic implants for glaucoma. Glaucoma is the second leading cause of adult blindness globally. Micro-invasive glaucoma surgery (MIGS) is the most promising and fastest-growing therapeutic option in the treatment of glaucoma. iSTAR has exclusive rights to the STAR material from the University of Washington in Seattle (USA) for ophthalmic use. This provides the foundation for the development of MINIject, which is designed to be a best in class MIGS device. The fast-growing glaucoma drainage device market is expected to reach $1bn worldwide by 2020. iSTAR Medical's management team and board have a successful track record in end-to-end product development, with proven clinical, regulatory and market access capabilities. The company is backed by specialised institutional and private investors.

keywords:N/A

N/A

Total Funding

66

Number of Employees

$16.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

iSTAR Medical News

2022-04-19 - Global Ophthalmic Implants Market Outlook & Forecasts 2022-2027: Rise of Artificial Intelligence for Detecting Diabetic Retinopathy & Increase in Use of Robotic Surgical Assistants for Eye Surgeries - ResearchAndMarkets.com

iSTAR Medical. Story continues. Key Topics Covered: 1 Research Methodology. 2 Research Objectives. 3 Research Process. 4 Scope & Coverage.

2022-04-17 - The ophthalmic implants market size is expected to grow at a CAGR of 6.5%.

iSTAR Medical GEOGRAPHIC OVERVIEW The increasing ageing population and raising awareness in the North American region are expected to drive...

2022-03-30 - iSTAR Medical Continues Market Expansion with First ...

MINIject® is iSTAR Medical's minimally-invasive glaucoma surgery (MIGS) implant and currently the only commercially available supraciliary MIGS...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.9M790%N/A
#2
$20M885%N/A
#3
N/A11154%N/A
#4
$16.9M121-8%N/A
#5
$82.5M3227%N/A